Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. May 21, 2005; 11(19): 2949-2952
Published online May 21, 2005. doi: 10.3748/wjg.v11.i19.2949
Published online May 21, 2005. doi: 10.3748/wjg.v11.i19.2949
Table 1 Clinical characteristics of patients with chronic hepatitis C (mean±SD).
| Woman/man (n) | 14/16 | |
| Age (yr) | 38.0±13.6 | |
| Duration of HCV infection (yr) | 2.4±1.7 | |
| Before treatment | After treatment | |
| ALT/AST (U/L) | 80±61/78±46 | 53±56/65±41 |
| ALP/GGT (U/L) | 89±22/62±41 | 79±21/55±26 |
| Albumin/gamma globulin (g/dL) | 3.7±0.4/1.2±0.3 | 3.9±0.9/1.3±0.5 |
| HCV-RNA positive (n) | 30 | 20 |
| Inflammatory activity (grading), score1 | ||
| Periportal: 1/2/3/4 (n) | 6/8/16/0 | 10/4/16/0 |
| Intralobular: 1/2/3/4 (n) | 18/12/0/0 | 16/14/0/0 |
| Fibrosis (staging), score:1/2/3/4 (n) | 20/8/2/0 | 16/12/2/0 |
- Citation: Anatol P, Danuta P, Janusz D, Bozena P. Expression of bcl-2 protein in chronic hepatitis C: Effect of interferon alpha 2b with ribavirin therapy. World J Gastroenterol 2005; 11(19): 2949-2952
- URL: https://www.wjgnet.com/1007-9327/full/v11/i19/2949.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i19.2949